SCHEMBL1373064

SCHEMBL1373064

CC(C)(C)OC(=O)N1C[C@H](Cc2cccc(F)c2)C[C@H]1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 4/20 0.43
NR1H3 Q13133 4/20 0.43
GPR119 Q8TDV5 1/20 0.43
CCR3 P51677 1/20 0.40
LTB4R Q15722 1/20 0.39
LTB4R2 Q9NPC1 1/20 0.39
AGTR2 P50052 4/20 0.39
CTSS P25774 1/20 0.38
CTSK P43235 1/20 0.38
MAOA P21397 2/20 0.37
MAOB P27338 2/20 0.37
JAK2 O60674 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
ATM Q13315 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21409216 1.00 NR1H2 (0.43) NR1H2NR1H3GPR119CCR3LTB4R
SCHEMBL2184149 0.88 DPP4 (0.44) NR1H2NR1H3GPR119AGTR2NPSR1
SCHEMBL1371753 0.88 DPP4 (0.44) NR1H2NR1H3GPR119AGTR2NPSR1
SCHEMBL6183348 0.88 NR1H2 (0.48) NR1H2NR1H3AGTR2JAK2ACE
SCHEMBL21409001 0.88 NR1H2 (0.48) NR1H2NR1H3AGTR2JAK2ACE
SCHEMBL1373084 0.88 NR1H2 (0.48) NR1H2NR1H3AGTR2JAK2ACE
SCHEMBL13687997 0.88 NR1H2 (0.48) NR1H2NR1H3AGTR2JAK2ACE
SCHEMBL7285245 0.88 NR1H2 (0.48) NR1H2NR1H3AGTR2JAK2ACE
SCHEMBL9542940 0.88 NR1H2 (0.48) NR1H2NR1H3AGTR2JAK2ACE
SCHEMBL6183345 0.88 NR1H2 (0.48) NR1H2NR1H3AGTR2JAK2ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791102-B2 Acetanilide sphingosine-1-phosphate receptor antagonists EXELIXIS, INC. (US) 2014-07-29 US disclosed
US-20110288076-A1 Sphingosine-1-Phosphate Receptor Antagonists EXELIXIS, INC. (US) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288076-A1 Sphingosine-1-Phosphate Receptor Antagonists S1PR1, S1PR2, S1PR3 NR1H2 253/4885NR1H3 287/4885GPR119 148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.